Comprehensive Review: The Role of Natural and Synthetic Aphrodisiacs in Managing Infertility and Sexual Dysfunction

Author

Binny Binoy, Dr. Abdul Vahab, Dr. Jyoti Harindran

Abstract

 Infertility and sexual dysfunction represent significant global health challenges affecting an estimated 10–15% of couples worldwide. Reproductive dysfunction encompasses male etiologies (such as erectile dysfunction, oligospermia, and asthenospermia) and female etiologies (including hypoactive sexual desire disorder, ovulatory dysfunctions, and endocrine pathologies). Aphrodisiacs categorized into natural phytotherapeutics and synthetic pharmacological agents play a major role in restoring reproductive capacity and sexual performance. Standard pharmaceutical options such as Sildenafil citrate, Tadalafil, Clomiphene citrate, and Cabergoline act via targeted biochemical mechanisms including phosphodiesterase type 5 (PDE5) inhibition, gonadotropin stimulation, and dopamine receptor agonism. Conversely, natural botanical aphrodisiacs like Tribulus terrestris, Panax ginseng, Lepidium meyenii (Maca), Withania somnifera, and Eurycoma longifolia modulate hypothalamic-pituitary-gonadal (HPG) axis signaling, enhance nitric oxide bioavailability, and mitigate cellular oxidative stress. This review provides a rigorous comparative synthesis of both synthetic and botanical aphrodisiacs, detailing their mechanisms of action, clinical evidence, side-effect profiles, drug interactions, and potential integration into contemporary reproductive medicine.

Keywords

Aphrodisiacs, Sildenafil Citrate, Infertility, Erectile Dysfunction, Spermatogenesis, Phytotherapy, Nitric Oxide, HPG Axis

Full Text:

Download Paper PDF

References

1. World Health Organization (WHO). (2021). WHO Laboratory Manual for the Examination and Processing of Human Semen(6th ed.). World Health Organization.
2. Agarwal, A., Mulgund, A., Hamada, A., & Chyette, M. R. (2015). A unique view on male infertility around the globe. Reproductive Biology and Endocrinology, 13(1), 37.
3. Corbin, J. D. (2004). Mechanisms of action of PDE5 inhibitors in erectile dysfunction. International Journal of Impotence Research, 16(1), S4-S7.
4. Tomar, A., & Singh, R. (2020). Ethnomedicinal plants used as aphrodisiacs in traditional systems of medicine: A review. Journal of Ethnopharmacology, 250, 112485.
5. Melis, M. R., & Argiolas, A. (1995). Dopamine and central control of sexual behavior: From past to the present. Progress in Neurobiology, 45(1), 1-43.
6. Ignarro, L. J., Byrns, R. E., Buga, G. M., & Wood, K. S. (1987). Endothelium-derived relaxing factor from active human and rabbit blood vessels is nitric oxide. Proceedings of the National Academy of Sciences, 84(24), 9265-9269.
7. Tenover, J. S., & Matsumoto, A. M. (1988). Clomiphene citrate therapy in chronic male infertility. Fertility and Sterility, 49(6), 1042-1048.
8. Goldstein, I., Lue, T. F., Padma-Nathan, H., et al. (1998). Oral sildenafil in the treatment of erectile dysfunction. New England Journal of Medicine, 338(20), 1397-1404.
9. Sher, G., & Fisch, J. D. (2002). Vaginal sildenafil citrate improves endometrial thickness and clinical pregnancy rates in cases of previous implantation failure. Fertility and Sterility, 78(5), 1073-1076.
10. Webb, D. J., Freestone, S., Allen, M. J., & Muirhead, G. J. (1999). Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and an alpha-blocker. The American Journal of Cardiology, 83(5), 21-28.
11. Ring, J. D., Lwin, L. T., & Köhler, T. S. (2016). Current review of testosterone deficiency and recovery using selective estrogen receptor modulators. Current Urology Reports, 17(5), 38.
12. Colao, A., Sarno, K., Landi, M. L., et al. (1997). Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. The Journal of Clinical Endocrinology & Metabolism, 82(11), 3574-3579.
13. De Rosa, M., Colao, A., Di Sarno, A., et al. (1998). Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males. European Journal of Endocrinology, 138(3), 286-293.
14. Clayton, A. H., Althof, S. E., Kingsberg, S., et al. (2019). Bremelanotide for female hypoactive sexual desire disorder: randomized studies. Obstetrics & Gynecology, 134(4), 715-725.
15. Gauthaman, K., & Adaikan, P. G. (2008). The hormonal effects of Tribulus terrestrisand its role in the management of male erectile dysfunction. Phytomedicine, 15(1-2), 44-54.
16. Roaiah, M. F., El Khayat, Y. I., Ammar, S. M., & Kamal, S. M. (2016). Pilot study on the effect of botanical medicine in treating oligospermia. International Journal of Fertility & Sterility, 10(2), 108-114.
17. De Andrade, E., de Azevedo, A. C., Washington, L., et al. (2007). Nitric oxide-dependent relaxation of corpus cavernosum and rabbit aorta by Panax ginseng. Asian Journal of Andrology, 9(2), 241-248.
18. Murphy, L. L., & Lee, T. J. (2002). Ginseng, sex, and the endothelium. Annals of the New York Academy of Sciences, 962(1), 372-381.
19. Gonzales, G. F. (2012). Ethnobiology and ethnopharmacology of Lepidium meyenii(Maca). Evidence-Based Complementary and Alternative Medicine, 2012, 193496.
20. Gonzales, G. F., Cordova, A., Vega, K., et al. (2003). Effect of Lepidium meyenii(Maca) on sexual desire and its absent relationship with serum testosterone. Andrologia, 35(6), 355-362.
21. Mahdi, A., Shukla, K. K., Ahmad, M. K., et al. (2009). Withania somnifera improves semen quality in stress-related male fertility. Evidence-Based Complementary and Alternative Medicine, 6(3), 325-331.
22. Ambiye, V. R., Langade, D., Dongre, S., et al. (2013). Clinical evaluation of spermatogenic activity of Ashwagandha in oligospermic males. Evidence-Based Complementary and Alternative Medicine, 2013, 571420.
23. Tambi, M. I., Imran, M. K., & Henkel, R. R. (2012). Standardized water-soluble extract of Eurycoma longifoliaas testosterone booster. Andrologia, 44(s1), 226-230.
24. Ismail, S. B., Wan Mohammad, W. M., George, A., et al. (2012). Randomized clinical trial on Eurycoma longifoliafor managing erectile function. Andrologia, 44(s1), 231-236.
25. Izzo, A. A., & Ernst, E. (2009). Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs, 69(13), 1777-1798.
26. Cohen, P. A., Avula, B., & Khan, I. A. (2012). Adulteration of herbal supplements with synthetic phosphodiesterase-5 inhibitors. JAMA Internal Medicine, 172(5), 425-427.
27. Ernst, E. (2002). Adulteration of Chinese herbal medicines with synthetic drugs: A systematic review. The Medical Journal of Australia, 176(12), 603-605.
28. Sandhu, J. S., Shah, N., Tanwar, S. D., et al. (2010). An efficacy study of Tribulus terrestrison male sexual function. Asian Journal of Andrology, 12(6), 720-724.
29. Agarwal, A., & Said, T. M. (2005). Oxidative stress, DNA damage and apoptosis in male infertility: A clinical approach. BJU International, 95(4), 503-507.